Brown TA 2nd, Mittendorf EA, Hale DF, Myers JW 3rd, et al. Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence. Breast Cancer Res Treat 2020 Apr 22. pii: 10.1007/s10549-020-05638.
PMID: 32323103